Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted psychotherapy for social anxiety in autistic young people
ACTRN12624001474549Phase 3Recruiting
- Sponsor
- Orygen
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midomafetamine, adenosine-5′-monophosphate, lorazepam and diphenhydramine, sponsored by Orygen. Started Sep 2025; status: recruiting.
02
Drugs
midomafetamineadenosine-5′-monophosphatelorazepamdiphenhydramine
Beyond the preview
Go deeper on ACTRN12624001474549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001474549.